Clinical Trials Browser

Unknown × Observational × Mesothelioma, Malignant × Clear all

Mesothelioma, Malignant

NCT05910112 2023-06-18

PROSPECT

Mesothelioma, Malignant, Pleural Diseases, Pleural Effusion, Pleural Neoplasms, Pneumothorax, Pleural Effusion, Malignant

NCT05042557 2021-09-13

Real World Study of MPM in China

Unknown

500 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT03210298 2019-10-08

PIPACRegis

Unknown

1,000 enrolled

GastrointestinalGynecologicOther solid neoplasmThoracic

Mesothelioma, Malignant, Appendiceal Neoplasms, Ascites, Gallbladder Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Peritoneal Neoplasms, Pleural Effusion, Pseudomyxoma Peritonei, Stomach Neoplasms, Colorectal Neoplasms

NCT03558932 2018-06-15

IP3R Modulation by Cancer Genes in Mesothelioma

Unknown

20 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT02761863 2018-02-23

Effect of Expression of CD74 and VEGF on Outcome of Treatment in Patients With Malignant Pleural Mesothelioma

Unknown

100 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

NCT03290183 2017-09-21

Confocal Laser Endomicroscopy in Pleural Malignancies

Unknown

20 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant, Pleural Diseases, Thymoma

NCT01343264 2011-04-28

Trimodality Therapy for Malignant Pleural Mesothelioma

Unknown

200 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT00899613 2009-12-15

Mesothelin and Osteopontin as Diagnostic Markers in Patients With Mesothelioma or Atypical Mesothelial Hyperplasia

Unknown

270 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant, Neoplasm Metastasis, Pleural Effusion, Malignant

Clinical Trials

SCITH-MESO

PROSPECT

Real World Study of MPM in China

PIPACRegis

IP3R Modulation by Cancer Genes in Mesothelioma

Effect of Expression of CD74 and VEGF on Outcome of Treatment in Patients With Malignant Pleural Mesothelioma

Confocal Laser Endomicroscopy in Pleural Malignancies

Trimodality Therapy for Malignant Pleural Mesothelioma

Mesothelin and Osteopontin as Diagnostic Markers in Patients With Mesothelioma or Atypical Mesothelial Hyperplasia